Product Images Opipza
View Photos of Packaging, Labels & Appearance
- Chemical Structure - opipza 01
- Figure 1 - opipza 02
- Figure 2 - opipza 03
- Figure 3 - opipza 04
- Figure 4 - opipza 05
- Figure 5 - opipza 06
- Figure 6 - opipza 07
- Figure 7 - opipza 08
- Figure A - opipza 09
- Figure B - opipza 10
- Figure C - opipza 11
- Figure D - opipza 12
- Figure E - opipza 13
- PRINCIPAL DISPLAY PANEL - 2 mg Film Pouch Carton - opipza 14
- PRINCIPAL DISPLAY PANEL - 5 mg Film Pouch Carton - opipza 15
- PRINCIPAL DISPLAY PANEL - 10 mg Film Pouch Carton - opipza 16
Product Label Images
The following 16 images provide visual information about the product associated with Opipza NDC 15370-403 by Carwin Pharmaceutical Associates, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - opipza 01
Figure 1 - opipza 02
This text provides information on the effect of various drugs on Aripiprazole. It mentions inhibitors and inducers of different CYP enzymes along with their respective drugs. The text also includes a chart showing the change in Aripiprazole levels and corresponding confidence intervals when interacting with other drugs.*
Figure 2 - opipza 03
Not available.*
Figure 3 - opipza 04
This text provides information on the effect of Aripiprazole on other drugs, specifically mentioning the potential interactions with various medications such as dextromethorphan, warfarin, valproate, and tiagabine. It also includes data on fold change and confidence intervals related to these drug interactions.*
Figure 4 - opipza 05
Figure 5 - opipza 06
Figure 6 - opipza 07
This text provides data on the proportion with relapse for Aripiprazole compared to Placebo, along with the number of subjects at risk and the days from randomization. The information can be used in a study or analysis on relapse rates between the two groups.*
Figure 7 - opipza 08
This data appears to show the least-squares mean change in the YGTSS Total TIC Score over the weeks of treatment with Aripiprazole (low and high doses) compared to placebo. The chart displays a change in the YGTSS Total TIC Score from baseline.*
Figure A - opipza 09
Figure B - opipza 10
Figure C - opipza 11
Figure D - opipza 12
Figure E - opipza 13
PRINCIPAL DISPLAY PANEL - 2 mg Film Pouch Carton - opipza 14
This is a product label for aripiprazole oral film. It comes in 30 pouches, with each pouch containing 1 oral film. The pharmacist is instructed to dispense the enclosed Medication Guide to each patient. It is specified not to cut or chew the oral film. The label includes the NDC code 15370-401-30 and mentions that it is for prescription use only. Additionally, there is barcode and lot number information provided at the bottom.*
PRINCIPAL DISPLAY PANEL - 5 mg Film Pouch Carton - opipza 15
This is a pharmaceutical product label for Aripiprazole oral film, with instructions not to cut or chew the film. Each package contains 30 pouches, each containing 1 oral film. The pharmacist is advised to dispense the enclosed Medication Guide to each patient. The label also includes the NDC number 15370-402-30.*
PRINCIPAL DISPLAY PANEL - 10 mg Film Pouch Carton - opipza 16
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
